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obtained a Cronbach’s a value of 0.62 which is compa-
rable to other versions. The Reactivity scale also had 3
items but its Cronbach’s a value was only 0.25. CON-
CLUSIONS: Childhood Asthma Questionnaire (CAQ-C)
is a simple and acceptable HRQoL instrument for asth-
matic teenagers. Most found the questionnaire easy and
fast to complete. The adapted version has Distress, Sever-
ity, Teenage and Active Quality of Living scales with good
internal consistency. However, further investigations are
needed to determine the internal structure of the scales 
by factor analysis and improve the Reactivity scale 
reliability.
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OBJECTIVES: Health status is an important outcome
measure in assessing treatment of asthmatic children.
However, measuring quality of life in asthmatic children
is difﬁcult, requiring measures that are both sensitive to
asthma and appropriate for children. This review sum-
marizes and evaluates published quality of life instru-
ments for pediatric asthma. METHODS: Articles were
obtained by searching the Medline up to date. The fol-
lowing ﬁelds were extracted from articles for each instru-
ment and summarized in a table: applicable age group,
type of respondent, means of administration, items and
domains, scaling, item selection, psychometric properties
and versions in foreign languages. Standard psychomet-
ric measures including internal consistency and test-retest
reliability, validity and responsiveness were chosen as
evaluation criteria. Alpha 0.7–0.9 was chosen as accept-
able range for reliability. RESULTS: 10 asthma- and 
children-speciﬁc instruments were identiﬁed (ASDQ,
AMA, CAQ, CHSA, FSI, HAY, ITG-CASF, LAQCA,
AAQOL, PAQLQ), in addition to three generic instru-
ments applied in pediatric asthma. These instruments
vary widely in age groups, length, items and domains,
means of administration, psychometric measures, and
versions and languages. The number of items ranges from
6–71, and number of domains 1–7. All instruments
contain physical symptoms or activities domains. All
measured internal consistency; only CAQ had domains
with alpha lower than the minimum requirement. ASDQ,
AMA, FSI and ITG-CASF had no test-retest reliability
reported, and HAY and CHSA had domains with low
reproducibility with alpha less than 0.7. Only HAY and
PAQLQ demonstrated good responsiveness by showing
changes in scores associated with clinical change. PAQLQ
is the only instrument satisfying all selected criteria.
CONCLUSIONS: Responsiveness to change is critical in
quality of life outcomes studies, yet many instruments did
not report this measure and therefore need further vali-
dation. Among 10 selected instruments, only PAQLQ sat-
isﬁed the selected criteria and is recommended to use for
ages 7–17.
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The efﬁcacy of mammographic screening in the reduction
of breast cancer (BC) mortality is controversial. OBJEC-
TIVE: To compare the results obtained by using only
“unbiased” trials in a meta-analysis, to what is obtained
when considering also all the trials that were previously
excluded, and to conduct a meta-analysis of the efﬁcacy
of mammographic screening, including data from all
sources (8 trials) and adjusting for qualitative bias.
METHODS: Fixed effects (FE) and random effects (RE)
inverse-variance weighted techniques were used to obtain
the pooled relative risk (RR) of death from BC in screened
groups vs. control groups. The pooled RR was also esti-
mated for all-cause mortality. Heterogeneity testing was
done for every set of studies pooled. Sensitivity analysis
to model choice and to inclusion criteria was carried out.
2. Quality measures were assigned to each trial, to
account for biases in design, intervention, patient follow-
up, outcome measurement and statistical analysis.
Quality-weighted RE analysis combined all 8 trials to esti-
mate the RR of BC mortality in screened groups vs.
control groups, in women of all ages. The analysis was
repeated in two age subgroups: women under 50, and
over 50. Cumulative and sensitivity analyses tested the
inclusion criteria and the quality weighting method.
RESULTS: Pooling all the trials for women at any age
showed screening to cause a signiﬁcant 20% reduction in
BC mortality, with a RE RR of 0.796(95% CI =
0.69–0.91). All-cause mortality was not signiﬁcant [RR =
0.99(95% CI = 0.94–1.04)]. Sensitivity analysis did not
change the estimates much. Quality-weighted analysis
resulted in RR of 0.84(95% CI = 0.73–0.96), 0.89(95%
CI = 0.74–1.09) and 0.81(95% CI = 0.71–0.92) in women
of all ages, under 50 and over 50, respectively. CON-
CLUSIONS: Mammography reduced breast cancer mor-
tality rates among women 40–74 years of age, with
greater risk reduction observed among older women. The
efﬁcacy of mammographic screening in the 40–49 age
group remains in question.
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OBJECTIVES: To evaluate effectiveness, costs and cus-
tomers’ satisfaction of delivery care in the Obstetrics Divi-
sion of the Hospital of Novara (Italy). METHODS: We
